Market Cap 2.41B
Revenue (ttm) 176.03M
Net Income (ttm) -116.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -66.35%
Debt to Equity Ratio 0.00
Volume 1,892,500
Avg Vol 1,553,026
Day's Range N/A - N/A
Shares Out 86.24M
Stochastic %K 4%
Beta N/A
Analysts Strong Sell
Price Target $37.00

Company Profile

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anat...

Industry: Health Information Services
Sector: Healthcare
Phone: 650 241 1221
Address:
135 Main Street, Suite 1000, San Francisco, United States
BioGem
BioGem Jul. 2 at 6:56 PM
$HTFL what I wrote continues to be true and there was no reason why this was pumped back above the lows of $25 lately. CEO is planning on selling tens of thousands of shares. And most insiders will be cashing out through 2026 away from this overvalued IPO.
0 · Reply
piorces
piorces Jun. 30 at 7:31 PM
$HTFL Didnt buy but any reason it plummeted?
0 · Reply
JR603
JR603 Jun. 30 at 4:24 PM
$HTFL What the hell ?????
0 · Reply
romura
romura Jun. 19 at 9:26 PM
$HTFL will be down to 27 on Monday
1 · Reply
MorganHoratio
MorganHoratio Jun. 15 at 4:41 PM
Here are some of the most prominent themes that our team is focusing on: Healthcare: $OSCR $HNGE $UNH $JNJ $HTFL This Healthcare watchlist captures the vital rotating theme of mid-2026: smart money is spilling out of legacy defensive value into high-pricing-power digital health and clinical AI disruptors. The underlying fundamentals here are stellar. Digital MSK leader $HNGE just hiked its full-year 2026 growth outlook to a rampant 40% at its June 10 Investor Day. Meanwhile, AI coronary pioneer $HTFL raised its fiscal guidance following a blowout 41% YoY Q1 revenue jump on rapid product adoption. Concurrently, insurtech leader $OSCR is holding multi-year highs, while legacy staples like $UNH (navigating its recent FTC insulin settlement) and $JNJ reset to deep structural support. Are you sheltering in cash-cow defensive giants like $UNH, or accumulating high-growth AI health turnarounds like $HNGE and $HTFL on this necessary dip?
0 · Reply
StageAnalysis
StageAnalysis Jun. 14 at 8:51 PM
Weekend Video Part 1: US Watchlist Stocks – $CAVA, $DXCM, $HTFL (7mins) ▪️Login for full length weekend video (53mins) discussing all the important data for the Stage Analysis method (made famous in Stan Weinstein's classic book) https://www.stageanalysis.net/blog/1392110/stage-analysis-members-video-14-june-2026
0 · Reply
StageAnalysis
StageAnalysis Jun. 13 at 11:23 PM
New Blog Post: US Stocks Watchlist There are 22 stocks highlighted from the weekends US stocks watchlist scans – $CAVA, $DXCM, $HTFL https://www.stageanalysis.net/blog/1391908/us-stocks-watchlist-15-june-2026
0 · Reply
SilverEagle
SilverEagle Jun. 10 at 4:32 PM
0 · Reply
LewisDaKat
LewisDaKat May. 31 at 12:00 PM
$HTFL Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million? https://marketwirenews.com/stock/htfl/news/is-heartflow-stock-a-buy-after-an-institutional-inve-4787568265673733.html?utm_source=stocktwits
0 · Reply
OMillionaires
OMillionaires May. 28 at 5:51 PM
This $HTFL is one of the best stories out there. AI, Healthcare, coverage from insurers... Tackling the leading cause of death in the U.S. This is a $100+ stock in the coming 6-12 months IMHO(if company executes)
0 · Reply
Latest News on HTFL
Heartflow initiated with a Buy at Freedom Capital

2026-06-30T20:35:17.000Z - 4 days ago

Heartflow initiated with a Buy at Freedom Capital


Heartflow falls -17.0%

2026-06-30T16:06:13.000Z - 4 days ago

Heartflow falls -17.0%


Heartflow falls -11.3%

2026-06-30T14:06:12.000Z - 4 days ago

Heartflow falls -11.3%


Heartflow price target lowered to $37 from $43 at Canaccord

2026-05-15T11:25:34.000Z - 7 weeks ago

Heartflow price target lowered to $37 from $43 at Canaccord


Heartflow price target raised to $37 from $35 at Wells Fargo

2026-05-15T11:08:49.000Z - 7 weeks ago

Heartflow price target raised to $37 from $35 at Wells Fargo


Heartflow reports Q1 EPS (32c), consensus (17c)

2026-05-14T21:07:40.000Z - 7 weeks ago

Heartflow reports Q1 EPS (32c), consensus (17c)


HeartFlow Earnings Call Transcript: Q1 2026

May 14, 2026, 4:30 PM EDT - 7 weeks ago

HeartFlow Earnings Call Transcript: Q1 2026


HeartFlow Earnings release: Q1 2026

May 14, 2026, 4:30 PM EDT - 7 weeks ago

HeartFlow Earnings release: Q1 2026


HeartFlow Quarterly report: Q1 2026

May 14, 2026, 4:30 PM EDT - 7 weeks ago

HeartFlow Quarterly report: Q1 2026


Heartflow initiated with an Outperform at William Blair

2026-05-04T10:26:10.000Z - 2 months ago

Heartflow initiated with an Outperform at William Blair


HeartFlow Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

HeartFlow Proxy statement: Proxy filing


HeartFlow Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

HeartFlow Proxy statement: Proxy filing


Heartflow files patent infringement lawsuit against Cleerly

2026-04-13T13:04:47.000Z - 2 months ago

Heartflow files patent infringement lawsuit against Cleerly


Heartflow Files Patent Infringement Lawsuit Against Cleerly

Apr 13, 2026, 8:30 AM EDT - 2 months ago

Heartflow Files Patent Infringement Lawsuit Against Cleerly


Heartflow price target lowered to $35 from $40 at JPMorgan

2026-03-19T11:52:57.000Z - 3 months ago

Heartflow price target lowered to $35 from $40 at JPMorgan


Heartflow price target raised to $43 from $40 at Canaccord

2026-03-19T10:47:04.000Z - 3 months ago

Heartflow price target raised to $43 from $40 at Canaccord


HeartFlow Earnings Call Transcript: Q4 2025

Mar 18, 2026, 4:30 PM EDT - 3 months ago

HeartFlow Earnings Call Transcript: Q4 2025


HeartFlow Annual report: Q4 2025

Mar 18, 2026, 4:30 PM EDT - 3 months ago

HeartFlow Annual report: Q4 2025


HeartFlow Earnings release: Q4 2025

Mar 18, 2026, 4:30 PM EDT - 3 months ago

HeartFlow Earnings release: Q4 2025


Heartflow reports Q4 EPS (29c), consensus (16c)

2026-03-18T20:21:23.000Z - 3 months ago

Heartflow reports Q4 EPS (29c), consensus (16c)


Heartflow sees FY26 revenue $218M-$22M, consensus $212.94M

2026-03-18T20:20:18.000Z - 3 months ago

Heartflow sees FY26 revenue $218M-$22M, consensus $212.94M


Heartflow announces clinical evidence, landmark registry launch

2026-03-16T12:12:03.000Z - 3 months ago

Heartflow announces clinical evidence, landmark registry launch


Heartflow announces expansion of its GAMEFILM Registry

2026-02-12T13:10:42.000Z - 5 months ago

Heartflow announces expansion of its GAMEFILM Registry


Heartflow initiated with an Overweight at Wells Fargo

2026-01-28T10:20:29.000Z - 5 months ago

Heartflow initiated with an Overweight at Wells Fargo


HeartFlow Slides: Investor presentation

Jan 12, 2026, 7:00 AM EST - 6 months ago

HeartFlow Slides: Investor presentation


HeartFlow Earnings Call Transcript: Q3 2025

Nov 12, 2025, 4:30 PM EST - 8 months ago

HeartFlow Earnings Call Transcript: Q3 2025


HeartFlow Quarterly report: Q3 2025

Nov 12, 2025, 4:30 PM EST - 8 months ago

HeartFlow Quarterly report: Q3 2025


HeartFlow Earnings release: Q3 2025

Nov 12, 2025, 4:30 PM EST - 8 months ago

HeartFlow Earnings release: Q3 2025


Heartflow Reports Third Quarter 2025 Financial Results

Nov 12, 2025, 4:01 PM EST - 8 months ago

Heartflow Reports Third Quarter 2025 Financial Results


HeartFlow Quarterly report: Q2 2025

Sep 19, 2025, 8:30 AM EDT - 10 months ago

HeartFlow Quarterly report: Q2 2025


HeartFlow Slides: Investor Presentation

Sep 9, 2025, 6:00 PM EDT - 10 months ago

HeartFlow Slides: Investor Presentation


Medtech firm Heartflow gains 47% in solid Nasdaq debut

Aug 8, 2025, 1:05 PM EDT - 11 months ago

Medtech firm Heartflow gains 47% in solid Nasdaq debut


Medtech firm Heartflow raises $316.7 million in US IPO

Aug 7, 2025, 8:54 PM EDT - 11 months ago

Medtech firm Heartflow raises $316.7 million in US IPO


HeartFlow Registration statement: Registration Filing

Aug 6, 2025, 8:00 AM EDT - 11 months ago

HeartFlow Registration statement: Registration Filing


HeartFlow Registration statement: Registration Filing

Aug 1, 2025, 8:00 AM EDT - 1 year ago

HeartFlow Registration statement: Registration Filing


BioGem
BioGem Jul. 2 at 6:56 PM
$HTFL what I wrote continues to be true and there was no reason why this was pumped back above the lows of $25 lately. CEO is planning on selling tens of thousands of shares. And most insiders will be cashing out through 2026 away from this overvalued IPO.
0 · Reply
piorces
piorces Jun. 30 at 7:31 PM
$HTFL Didnt buy but any reason it plummeted?
0 · Reply
JR603
JR603 Jun. 30 at 4:24 PM
$HTFL What the hell ?????
0 · Reply
romura
romura Jun. 19 at 9:26 PM
$HTFL will be down to 27 on Monday
1 · Reply
MorganHoratio
MorganHoratio Jun. 15 at 4:41 PM
Here are some of the most prominent themes that our team is focusing on: Healthcare: $OSCR $HNGE $UNH $JNJ $HTFL This Healthcare watchlist captures the vital rotating theme of mid-2026: smart money is spilling out of legacy defensive value into high-pricing-power digital health and clinical AI disruptors. The underlying fundamentals here are stellar. Digital MSK leader $HNGE just hiked its full-year 2026 growth outlook to a rampant 40% at its June 10 Investor Day. Meanwhile, AI coronary pioneer $HTFL raised its fiscal guidance following a blowout 41% YoY Q1 revenue jump on rapid product adoption. Concurrently, insurtech leader $OSCR is holding multi-year highs, while legacy staples like $UNH (navigating its recent FTC insulin settlement) and $JNJ reset to deep structural support. Are you sheltering in cash-cow defensive giants like $UNH, or accumulating high-growth AI health turnarounds like $HNGE and $HTFL on this necessary dip?
0 · Reply
StageAnalysis
StageAnalysis Jun. 14 at 8:51 PM
Weekend Video Part 1: US Watchlist Stocks – $CAVA, $DXCM, $HTFL (7mins) ▪️Login for full length weekend video (53mins) discussing all the important data for the Stage Analysis method (made famous in Stan Weinstein's classic book) https://www.stageanalysis.net/blog/1392110/stage-analysis-members-video-14-june-2026
0 · Reply
StageAnalysis
StageAnalysis Jun. 13 at 11:23 PM
New Blog Post: US Stocks Watchlist There are 22 stocks highlighted from the weekends US stocks watchlist scans – $CAVA, $DXCM, $HTFL https://www.stageanalysis.net/blog/1391908/us-stocks-watchlist-15-june-2026
0 · Reply
SilverEagle
SilverEagle Jun. 10 at 4:32 PM
0 · Reply
LewisDaKat
LewisDaKat May. 31 at 12:00 PM
$HTFL Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million? https://marketwirenews.com/stock/htfl/news/is-heartflow-stock-a-buy-after-an-institutional-inve-4787568265673733.html?utm_source=stocktwits
0 · Reply
OMillionaires
OMillionaires May. 28 at 5:51 PM
This $HTFL is one of the best stories out there. AI, Healthcare, coverage from insurers... Tackling the leading cause of death in the U.S. This is a $100+ stock in the coming 6-12 months IMHO(if company executes)
0 · Reply
romura
romura May. 22 at 8:37 PM
$HTFL will hit $35 to 36 next week, I was 31.50 this morning. very positive news
0 · Reply
BioGem
BioGem May. 21 at 1:02 PM
$HTFL A short position here is not unreasonable. It is extremely overvalued at anything above 20 dollars: -Valuation on EV/Sales ratio is through the roof. -Growth will be slowing sharply by next year. -While operating expenses expanding the sales team is skyrocketing. -Losses and cash burn are accelerating. -Cash is dwindling and they will need a capital raise in the near future. -Too many stock awards given cheaply in the money, and insiders can't stop selling their shares to retail. -Analysts have lowered their price targets post Q1 report.
0 · Reply
BHguy77
BHguy77 May. 15 at 7:14 PM
$HTFL why the big drop today?
0 · Reply
OpenOutcrier
OpenOutcrier May. 15 at 12:37 PM
$HTFL (-0.7% pre) Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance https://ooc.bz/l/102484
0 · Reply
OMillionaires
OMillionaires May. 15 at 11:03 AM
$HTFL PT raised to $37 from $35 at Wells Fargo - keeps Overweight rating
0 · Reply
MarketBeat
MarketBeat May. 15 at 1:10 AM
https://marketbeat.com/a/8655143/ $HTFL Heartflow Q1 Earnings Call Highlights
0 · Reply
EarningsInsider
EarningsInsider May. 15 at 12:02 AM
https://www.marketbeat.com/earnings/reports/2026-5-14-heartflow-inc-stock/ $HTFL Heartflow Earnings Transcript
0 · Reply
Doozio
Doozio May. 14 at 11:25 PM
$HTFL ONTO 🐒🍌🧠⏰♾️
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 14 at 8:09 PM
$HTFL Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.32 up 93.90% YoY • Reported revenue of $52.59M up 41.34% YoY • Heartflow raised its full-year 2026 total revenue guidance to $228M to $232M, representing 29% to 32% growth year-over-year, and maintained Non-GAAP gross margin at approximately 81%.
0 · Reply
marley401
marley401 May. 14 at 7:57 PM
$HTFL few er lotto calls
0 · Reply
MonkeyBananaGenius
MonkeyBananaGenius May. 14 at 6:40 PM
$HTFL earnings tonight. Looks ready
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 11 at 1:07 PM
The Future of Intoxication Detection May Be in Your Voice $MBIO.CN $MBQIF $HTFL $RXRX $TEM $BFLY https://ibn.fm/hAnhh
0 · Reply